Loading...
Acetyl-CoA carboxylase 1 regulates endothelial cell migration by shifting the phospholipid composition.
Glatzel, Daniel K Koeberle, Andreas Pein, Helmut Löser, Konstantin Stark, Anna Keksel, Nelli Werz, Oliver Bischoff, Iris Fürst, Robert
Glatzel, Daniel K
Koeberle, Andreas
Pein, Helmut
Löser, Konstantin
Stark, Anna
Keksel, Nelli
Werz, Oliver
Bischoff, Iris
Fürst, Robert
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2018-02
Submitted date
Files
Other Titles
Abstract
The enzyme acetyl-CoA carboxylase (ACC) plays a crucial role in fatty acid metabolism. In recent years, ACC has been recognized as a promising drug target for treating different diseases. However, the role of ACC in vascular endothelial cells (ECs) has been neglected so far. To characterize the role of ACC, we used the ACC inhibitor, soraphen A, as a chemical tool, and also a gene silencing approach. We found that ACC1 was the predominant isoform in human umbilical vein ECs as well as in human microvascular ECs and that soraphen A reduced the levels of malonyl-CoA. We revealed that ACC inhibition shifted the lipid composition of EC membranes. Accordingly, membrane fluidity, filopodia formation, and migratory capacity were reduced. The antimigratory action of soraphen A depended on an increase in the cellular proportion of PUFAs and, most importantly, on a decreased level of phosphatidylglycerol. Our study provides a causal link between ACC, membrane lipid composition, and cell migration in ECs. Soraphen A represents a useful chemical tool to investigate the role of fatty acid metabolism in ECs and ACC inhibition offers a new and valuable therapeutic perspective for the treatment of EC migration-related diseases.
Citation
Acetyl-CoA carboxylase 1 regulates endothelial cell migration by shifting the phospholipid composition. 2018, 59 (2):298-311 J. Lipid Res.
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
1539-7262